Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine
Clinical trial NCT00962780 · COMPLETED
Trial details
- NCT number
- NCT00962780
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2013-04-01
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.